YBYamil Ballestas-Casallas

Yamil Ballestas-Casallas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yamil Ballestas-Casallas has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular docking studies of 4-nitromonosubstituted chalcone derivatives as cyclooxygenase-2 (COX-2) inhibitors

    by Danilo L. Ariza-Rua, Edisson Chavarro-Mesa, Yamil Ballestas-Casallas, Juan Rebollo-Perez, Wilson Maldonado-Rojas

    A series of 4-nitrochalcone derivatives was designed and docked into the crystal structures of the cyclooxygenase-2 (COX-2) enzyme to calculate the binding affinity of each derivative within the protein active site. We employed the non-selective COX-2 inhibitor ibuprofen and the selective COX-2 inhibitor celecoxib as references to compare the interaction and likely inhibitory impact of the 4-nitrochalcone derivatives. Ibuprofen showed lower affinity values than 3’-COOH-4-nitrochalcone, 3’-CF3-4-nitrochalcone and 3’-NO2-4-nitrochalcone. These derivatives act in the same way as celecoxib at the active site of COX-2. This information could be useful in the development of monosubstituted 4-nitrochalcone derivatives as anti-inflammatory compounds.